Sveriges mest populära poddar
Prostate Cancer Update
Prostate Cancer Update

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

52 min•15 maj 2026
Logga in för att spara

Om avsnittet

Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer.

CME information and select publications here.

Fler avsnitt

Visa alla avsnitt av Prostate Cancer Update

Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal

52 min

Metastatic Bladder Cancer — Rapid Case Review Issue 8

26 min

Metastatic Bladder Cancer — Rapid Case Review Issue 7

36 min

Prostate Cancer — The Optimal Use of Hormonal Therapy

59 min

AKT Inhibition in Prostate Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

18 min

For Oncology Nurses: Prostate Cancer — Proceedings from the 2026 Annual ONS Congress

1 tim 28 min

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

15 min

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

20 min

AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

19 min

AKT Inhibition in Prostate Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

17 min

Prostate Cancer Update med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.